Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2026-05-24 Share Issue/Capital Cha…
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - LGP 8 pages 24.5KB
Share Issue/Capital Change Classification · 90% confidence The document is an ASX Appendix 2A “Application for quotation of securities,” detailing the issuance of new ordinary shares upon conversion of options and the application to quote these securities. This is an announcement of a capital change (new share issuance/conversion). Under our taxonomy, such filings are classified as Share Issue/Capital Change (SHA).
2026-05-24 English
Court Approves the Scheme and Scheme Becomes Effective 4 pages 339.2KB
M&A Activity Classification · 90% confidence The document is an ASX announcement by Little Green Pharma Ltd regarding the court approval and implementation of a scheme of arrangement to acquire 100% of Cannatrek Ltd, detailing effective dates, lodgement of court orders, and scheme consideration. This is clearly an announcement related to a merger/acquisition transaction rather than a standalone financial report, regulatory notice, or shareholder vote result. Therefore it fits the M&A Activity category.
2026-05-24 English
Results of General Meeting 2 pages 493.6KB
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is an ASX announcement providing detailed results of shareholder voting at the General Meeting held on 22 May 2026, including proxy and poll votes and resolution outcomes. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA), not a report itself or other category.
2026-05-21 English
Corporate Governance Statement and Appendix 4G 31 pages 643.6KB
Governance Information Classification · 95% confidence The document is the full Corporate Governance Statement of Little Green Pharma for the year ended 31 March 2026. It details the company’s governance practices, board charter, roles and responsibilities, diversity policy, and committee processes against the ASX Corporate Governance Principles. This aligns precisely with the definition of Governance Information (CGR) as a report on internal rules, board structure, and governance practices.
2026-05-20 English
Appendix 4E and 2026 Annual Report 72 pages 3.5MB
Annual Report Classification · 95% confidence The document is titled “Annual Report 2026 for the year ended 31 March 2026” and includes comprehensive financial statements, notes to the consolidated financial statements, directors’ report, auditor’s report, ESG report, chairman’s letter, and full audited consolidated statements. It clearly constitutes the full year-end annual report rather than a brief announcement or summary. Therefore, it should be classified as an Annual Report. FY 2026
2026-05-20 English
Investor Presentation - March 2026 Quarterly and Appendix 4C 17 pages 4.4MB
Investor Presentation Classification · 95% confidence The document is structured as a slide presentation with disclaimers, forward-looking statements, graphics, and detailed financial and strategic commentary, explicitly titled “Investor presentation” (ASX:LGP MAY 2026 Quarterly & Appendix 4C Investor presentation). It is not an official annual or interim report but a slide deck for investors, matching the definition of an Investor Presentation.
2026-05-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.